Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

South Korea flag South Korea · Delayed Price · Currency is KRW
82,300
+900 (1.11%)
At close: Oct 2, 2025
1.11%
Market Cap1.08T
Revenue (ttm)1.66T
Net Income (ttm)60.99B
Shares Out13.18M
EPS (ttm)4,623.22
PE Ratio17.71
Forward PE15.12
Dividend1,100.00 (1.34%)
Ex-Dividend DateDec 27, 2024
Volume34,919
Average Volume54,858
Open81,700
Previous Close81,400
Day's Range81,200 - 82,400
52-Week Range70,900 - 110,476
Beta0.61
RSI49.20
Earnings DateOct 24, 2025

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair colo... [Read more]

Sector Healthcare
Founded 1941
Employees 2,253
Stock Exchange Korea Stock Exchange
Ticker Symbol 185750
Full Company Profile

Financial Performance

In 2024, KRX:185750's revenue was 1.59 trillion, a decrease of -4.97% compared to the previous year's 1.67 trillion. Earnings were 109.07 billion, a decrease of -48.68%.

Financial Statements

News

There is no news available yet.